Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

67 results about "ATP synthase" patented technology

ATP synthase is an enzyme that creates the energy storage molecule adenosine triphosphate (ATP). ATP is the most commonly used "energy currency" of cells for all organisms. The formation of ATP from ADP and Pᵢ is energetically unfavorable and would normally proceed in the reverse direction. In order to drive this reaction forward, ATP synthase couples ATP synthesis during cellular respiration to an electrochemical gradient created by the difference in proton (H⁺) concentration across the mitochondrial membrane in eukaryotes or the plasma membrane in bacteria. During photosynthesis in plants, ATP is synthesized by ATP synthase using a proton gradient created in the thylakoid lumen through the thylakoid membrane and into the chloroplast stroma.

Method for cultivating transgenic plant with improved insect resistance by using RNA interference technology and special DNA fragment thereof

The invention discloses a method for cultivating a transgenic plant with improved insect resistance by using RNA interference technology and a special DNA fragment thereof. The DNA fragment is a gene fragment shown as a formula I, wherein a forward sequence (SEQ) is any one fragment which at least comprises 19bp in full-length cDNA fragments of an ATP synthase E subunit gene; a reverse sequence (SEQ) and the forward sequence (SEQ) are mutually reversely complementary; X is a spacer sequence between the forward sequence (SEQ) and the reverse sequence (SEQ), and the X and the forward sequence (SEQ) or the X and the reverse sequence (SEQ) are both not complementary mutually; and the full-length cDNA of the ATP synthase E subunit gene is shown as a sequence 1 in a sequence table. The invention also aims to provide application of the ATP synthase E subunit gene serving as an RNA interference target gene in cultivating the transgenic plant with improved insect resistance. Experiments prove that aphids inoculated to wild-type tobacco grow and reproduce normally; and aphids inoculated to transgenic tobacco starts to die on the fourth day, dead aphid bodies is blackened after five days and no live aphids can be seen after seven days. The formula (I) is forward sequence (SEQ)-X- reverse sequence (SEQ).
Owner:INST OF MICROBIOLOGY - CHINESE ACAD OF SCI

Compositions and Methods for Bioelectricity Production

The invention provides a microbial fuel cell having a dissimilatory metal-reducing microbe expressing exogenous or native ATPase subunits, the ATPase subunits assembling into an active ATP synthase and consuming ATP in a futile cycle. The dissimilatory metal-reducing microbe can include an organism selected from the organisms set forth in Table 1. The one or more exogenous ATPase subunits can include a subunit selected from the ATPase subunits set forth in Tables 2 or 3. Also provided is a microbial fuel cell having a dissimilatory metal-reducing microbe expressing one or more exogenous genes encoding a gene product that promotes ATP consumption, the gene products of the one or more exogenous genes having an activity that reduces ATP synthesis, increases ATP consumption or both. The one or more gene products can increase ATP consumption through a futile cycle or through altering a metabolic reaction directly involved in ATP synthesis. Further provided is a microbial fuel cell having a dissimilatory metal-reducing microbe expressing one or more exogenous genes encoding a gene products that increases the electron/mole ratio compared to an unmodified microbe, wherein the increased ratio enhances electron transfer to an electrode. A method of producing electricity from an microbial organism is further provided. The method includes: (a) culturing a microbial fuel cell under anaerobic conditions sufficient for growth, the microbial fuel cell comprising a dissimilatory metal-reducing microbe expressing exogenous ATPase subunits, the ATPase subunits assembling into an active ATP synthase and consuming ATP in a futile cycle when grown under anaerobic conditions, and (b) capturing electrons produced by an increased ATP demand with an electron acceptor.
Owner:GENOMATICA INC

Compositions and methods for promoting or inhibiting angiogenesis

Compounds, compositions and methods for promoting or inhibiting angiogenesis, and screening methods for identifying compounds are disclosed. The compounds bind to F1 ATP synthase particularly to the alpha and / or beta subunits of F1 ATP synthase. When bound to these subunits, they can function as angiostatin agonists, antagonists, partial agonists, inverse agonists, or allosteric modulators. When the compounds mimic or enhance the activity of angiostatin, they inhibit angiogenesis. When the compounds inhibit the ability of angiostatin to bind F1 ATP synthase and are either inactive at inhibiting angiogenesis or directly promote angiogenesis, or if they inhibit the activity of angiostatin, they promote angiogenesis. The compounds can be, for example, antibodies, antibody fragments, enzymes, peptides, nucleic acids such as oligonucleotides, or small molecules. The antibodies can be monoclonal, humanized, or polyclonal antibodies. The compounds can be conjugated to or combined with various cytotoxic agents and / or labeled compounds. Methods for promoting angiogenesis can be used to introduce vasculature to areas in a patient that can benefit from such increased vasculature. Methods for inhibiting angiogenesis can be used to treat disorders mediated by angiogenesis, for example, tumors, autoimmune disorders such as rheumatoid arthritis, and the like.
Owner:DUKE UNIV +1

Productivity and Bioproduct Formation in Phototropin Knock/Out Mutants in Microalgae

Phototropin is a blue light receptor, which mediates a variety of blue-light elicited physiological processes in plants and algae. In higher plants these processes include phototropism, chloroplast movement and stomatal opening. In the green alga Chlamydomonas reinhardtii, phototropin plays a vital role in progression of the sexual life cycle and in the control of the eye spot size and light sensitivity Phototropin is also involved in blue-light mediated changes in the synthesis of chlorophylls, carotenoids, chlorophyll binding proteins. We compared the transcriptome of phototropin knock out (PHOT KO) mutant and wild-type parent to analyze differences in gene expression in high light grown cultures (500 μmol photons m−2 s−1). Our results indicate the up-regulation of genes involved in photosynthetic electron transport chain, carbon fixation pathway, starch, lipid, and cell cycle control genes. With respect to photosynthetic electron transport genes, genes encoding proteins of the cytochrome b6f and ATP synthase complex were up regulated potentially facilitating proton-coupled electron transfer. In addition genes involved in limiting steps in the Calvin cycle Ribulose-1,5-bisphosphate carboxylase/oxygenase (RuBisCO), Sidoheptulose 1,7 bisphosphatase (SBPase), Glyceraldehyde-3-phosphate dehydrogenase (3PGDH) and that mediate cell-cycle control (CDK) were also up regulated along with starch synthase and fatty acid biosynthesis genes involved in starch and lipid synthesis. In addition, transmission electron micrographs show increased accumulation of starch granules in PHOT mutant compared to wild type, which is consistent with the higher expression of starch synthase genes. Collectively, the altered patterns of gene expression in the PHOT mutants were associated with a two-fold increase in growth and biomass accumulation compared to wild type when grown in environmental photobioreactors (Phenometrics) that simulate a pond environment. In conclusion, our studies suggest that phototropin may be a master gene regulator that suppresses rapid cell growth and promotes gametogenesis and sexual recombination in wild type strains.
Owner:NMC INC +1

Molecular motor lipid vesicle composition as well as preparation method and application thereof

The invention relates to a molecular motor lipid vesicles composition, a preparation method and an application of the composition. The composition has the effects of improving the solubility and long-term effect of molecular motors and promoting absorption, and the assembly structure of the molecular motor lipid vesicles is a closed structure or a cell compartment containing molecular motor ATP synthase and lipid bilayers thereof and having biological membrane properties, the molecular motor lipid vesicles called vesicles, niosolnes are also called liposomes in the past, the biological membrane containing the molecular motor has a lipid bilayer structure, so that the biological membrane has moisturizing, whitening and anti-aging effects when being applied to the field of cosmetics, achieves the effects of improving the stability, improving the solubility and the long-term effect of the molecular motor and promoting absorption, and is simple and convenient in production process, and low in cost, and the defects that the lipidosome adopting phospholipid needs to be purified, is easy to oxidize and degrade and the like are avoided.
Owner:HANGZHOU UMOTOR BIOTECH CO LTD

ATPSb gene related to survival of brown planthopper and encoded protein as well as application thereof

ActiveCN107988244AReduced survival rateMitigate immediate harmBiocideHydrolasesNucleotideOrganism
The invention discloses a ATPSb gene related to survival of a brown planthopper and encoded protein as well as application thereof. The ATPSb gene is characterized in that the ATPSb gene has nucleotide sequence shown as SEQ ID NO: 1, a gene code ATP synthase b subunit, plays an important role in keeping normal survival of the brown planthopper, which cause the decreasing of the survival rate if the role is inhibited. The protein encoded by the ATPSb gene has the amino sequence shown as SEQ ID NO: 2. The application of the ATPSb gene and encoded protein is used for researching pesticide and biologically controlling the brown planthopper. According to the invention, the RNA interference on the ATPSb gene is successfully conducted, the results show that the survival rate of pests is reduced,the survival of the pests is obviously inhabited, so that the functions that the pests are inhabited and the biologically controlling is fully realized are hopefully realized at the same time.
Owner:CHINA JILIANG UNIV

Preparation method and use of chimeric human anti-murine monoclonal antibody for inhibiting angiostatin acceptor

InactiveCN102464720AInhibit synthesisSuitable for in vivo applicationFungiHybrid immunoglobulinsApoptosisCell membrane
The invention discloses a chimeric human anti-murine monoclonal antibody for inhibiting an angiostatin acceptor, and its preparation method and use. The chimeric human anti-murine monoclonal antibody for inhibiting the angiostatin acceptor comprises an antibody light-chain unit and an antibody heavy-chain unit, wherein a heavy chain is connected to a light chain through a disulfide bond. The chimeric human anti-murine monoclonal antibody for inhibiting the angiostatin acceptor is a chimeric antibody, can maintain human adenosine triphosphate (ATP) synthase-resistant activity and is suitable for be used in vivo. The chimeric human anti-murine monoclonal antibody for inhibiting the angiostatin acceptor has obvious effects of inhibiting proliferation of a breast cancer cell MDA-MB-231, has certain effects of inhibiting proliferation of a lung cancer cell A549, a liver cancer cell HepG2, and a cell PC-3 and a cell HUVEC of the prostate, causes apoptosis of associated cells, specifically binds with tumor tissue, and specifically identifies a tumor cell membrane and an endothelial cell membrane. In addition, the chimeric human anti-murine monoclonal antibody for inhibiting the angiostatin acceptor can inhibit activity of ATP synthase on surfaces of tumor cell membranes and endothelial cell membranes, formation of vessels in vitro, and moving of the cell HUVEC and the breast cancer cell MDA-MB-231 in vitro, and is meaningful to antitumor therapy.
Owner:SUZHOU INDAL PARK HUMAN ANTIBODOMICS DEV

Method for collecting nitrosobacteria

The invention discloses a method for collecting nitrosobacteria. The method comprises the following steps: 1) preparing a protective agent, namely adding 2-4 parts of sodium glutamate, 18-25 parts oftripotassium phosphate and 1-3 parts of cysteine into 90-120 parts of sterile water, and uniformly mixing to obtain the protective agent; 2) adding thalli, namely 0.8-1.2 times that of the volume of nitrosobacteria thalli into the protective agent obtained in the step 1), and performing shock re-suspending so as to obtain a mixed solution; and 3) freezing and preserving, namely performing freeze drying on the mixed solution obtained in the step 2), freezing and preserving at a temperature of 70-90 DEG C, and performing activation transfer every 2-3 months. The method disclosed by the inventionhas the beneficial effects that damage of freeze drying on the nitrosobacteria thalli can be greatly reduced, and the nitrosobacteria survival rate and activities of ATP synthase and ammonia monooxygenase (AMO) in the preservation process are improved.
Owner:ZHEJIANG ACADEMY OF AGRICULTURE SCIENCES

Atp synthase inhibitors and steroid alkaloids and uses thereof as antimicrobial agents and as potentiators for aminoglycosides against pathogenic bacteria

The present invention provides bacterial ATP synthase inhibitors such as a compound of formula (I): (Formula (I)) (A) in combination with an aminoglycoside antibiotic for preventing or treating a bacterial infection in a subject; or (B) (a) for preventing or treating an infection caused by an electron transport-deficient bacteria in a subject; or (b) for the disinfection, sterilization and / or antisepsis of an object contaminated with an electron transport-deficient bacteria. There are provided compositions and kits using such compounds and inhibitors.
Owner:SCOPRA SCI & GENIE SEC

Compositions and methods for promoting or inhibiting angiogenesis

Compounds, compositions and methods for promoting or inhibiting angiogenesis, and screening methods for identifying compounds are disclosed. The compounds bind to F1 ATP synthase particularly to the alpha and / or beta subunits of F1 ATP synthase. When bound to these subunits, they can function as angiostatin agonists, antagonists, partial agonists, inverse agonists, or allosteric modulators. When the compounds mimic or enhance the activity of angiostatin, they inhibit angiogenesis. When the compounds inhibit the ability of angiostatin to bind F1 ATP synthase and are either inactive at inhibiting angiogenesis or directly promote angiogenesis, or if they inhibit the activity of angiostatin, they promote angiogenesis. The compounds can be, for example, antibodies, antibody fragments, enzymes, peptides, nucleic acids such as oligonucleotides, or small molecules. The antibodies can be monoclonal, humanized, or polyclonal antibodies. The compounds can be conjugated to or combined with various cytotoxic agents and / or labeled compounds. Methods for promoting angiogenesis can be used to introduce vasculature to areas in a patient that can benefit from such increased vasculature. Methods for inhibiting angiogenesis can be used to treat disorders mediated by angiogenesis, for example, tumors, autoimmune disorders such as rheumatoid arthritis, and the like.
Owner:DUKE UNIV +1

Oligonucleotide sequences that identify species of animal

Methods for identifying animal species involving amplifying a DNA fragment by PCR using a DNA in a sample as a template and animal-specific DNA sequences as a primer pair, the animal-specific DNA sequences derived from a ATP synthase subunit 8 gene or a region proximal thereto of a mitochondrial genome; and detecting the amplified DNA fragment.
Owner:NAT INST OF AGROBIOLOGICAL SCI +1
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products